FTO (Freedom to Operate) in the Pharmaceutical Industry
FTO licensing in the pharmaceutical industry deserves special consideration because of the large economic scale of the market, expensive cost of R&D, extremely low success rate, and easy duplication of the drug. Taking these unique aspects into consideration, the author first explaines how to pe...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Electrónico Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
Nomos Verlagsgesellschaft mbH & Co. KG
2018
|
| Colección: | Munich Intellectual Property Law Center - MIPLC
|
| Materias: | |
| Acceso en línea: | DOAB: download the publication DOAB: description of the publication |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | FTO licensing in the pharmaceutical industry deserves special consideration because of the large economic scale of the market, expensive cost of R&D, extremely low success rate, and easy duplication of the drug. Taking these unique aspects into consideration, the author first explaines how to perform a good FTO search and conclude an appropriate FTO licensing agreement, and then points out two issues; (i) the issue of FTO licensing and EU competition, especially the unreasonable application of the Guideline, and (ii) the issue of FTO licensing and differentiating between a bio venture company and a pharmaceutical company. Solutions for these issues are proposed. |
|---|---|
| ISBN: | /dx.doi.org/10.5771/9783845294018 9783845294018 |
| Acceso: | Open Access |